Possible Doxazosin-Induced Leukopenia

Authors

  • Séadna Ledger London Health Sciences Centre
  • Rahul Rai Mainra London Health Sciences Centre

DOI:

https://doi.org/10.4212/cjhp.v57i5.396

Abstract

INTRODUCTION

Doxazosin is a selective long-acting a1-adrenergic antagonist. It is indicated for the treatment of benign prostatic hyperplasia and stage I and II (mild to moderate) essential hypertension.1 A MEDLINE search revealed no previous reports of leukopenia associated with the use of doxazosin.

Downloads

Download data is not yet available.

Downloads

Issue

Vol. 57 No. 5 (2004)

Section

Case Report(s) / Observation(s) clinique(s)

License

Copyright © Canadian Society of Healthcare-Systems Pharmacy.

After publication of a manuscript in the CJHP, the authors of the manuscript must obtain written permission from the CSHP (publications@cshp.ca) before reproducing any text, figures, tables, or illustrations from the work in future works of their own. If a submitted manuscript is declined for publication in the CJHP, all said rights shall revert to the authors. Please note that any forms (e.g., preprinted orders and patient intake forms) used by a specific hospital or other health care facility and included as illustrative material with a manuscript are exempt from this copyright transfer. The CJHP will require a letter from the hospital or health care facility granting permission to publish the document(s).